{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:21:20Z","timestamp":1794590480926,"version":"4.9.1"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Initiatives to eradicate malaria have a good impact on\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    malaria worldwide.\n                    <jats:italic>P. vivax<\/jats:italic>\n                    , however, still presents significant difficulties. This is due to its unique biological traits, which, in comparison to\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    , pose serious challenges for malaria elimination approaches.\n                    <jats:italic>P. vivax's<\/jats:italic>\n                    numerous distinctive characteristics and its ability to live for weeks to years in liver cells in its hypnozoite form, which may elude the human immune system and blood-stage therapy and offer protection during mosquito-free seasons. Many malaria patients are not fully treated because of contraindications to primaquine use in pregnant and nursing women and are still vulnerable to\n                    <jats:italic>P. vivax<\/jats:italic>\n                    relapses, although there are medications that could radical cure\n                    <jats:italic>P. vivax<\/jats:italic>\n                    . Additionally, due to CYP2D6's highly variable genetic polymorphism, the pharmacokinetics of primaquine may be impacted. Due to their inability to metabolize PQ, some CYP2D6 polymorphism alleles can cause patients to not respond to treatment. Tafenoquine offers a radical treatment in a single dose that overcomes the potentially serious problem of poor adherence to daily primaquine. Despite this benefit, hemolysis of the early erythrocytes continues in individuals with G6PD deficiency until all susceptible cells have been eliminated. Field techniques such as microscopy or rapid diagnostic tests (RDTs) miss the large number of submicroscopic and\/or asymptomatic infections brought on by reticulocyte tropism and the low parasitemia levels that accompany it. Moreover,\n                    <jats:italic>P. vivax<\/jats:italic>\n                    gametocytes grow more quickly and are much more prevalent in the bloodstream\n                    <jats:italic>. P. vivax<\/jats:italic>\n                    populations also have a great deal of genetic variation throughout their genome, which ensures evolutionary fitness and boosts adaptation potential. Furthermore,\n                    <jats:italic>P. vivax<\/jats:italic>\n                    fully develops in the mosquito faster than\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    . These characteristics contribute to parasite reservoirs in the human population and facilitate faster transmission. Overall, no genuine chance of eradication is predicted in the next few years unless new tools for lowering malaria transmission are developed (i.e., malaria elimination and eradication). The challenging characteristics of\n                    <jats:italic>P. vivax<\/jats:italic>\n                    that impede the elimination and eradication of malaria are thus discussed in this article.\n                  <\/jats:p>","DOI":"10.1186\/s40794-022-00185-3","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:09:25Z","timestamp":1671095365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication"],"prefix":"10.1186","volume":"8","author":[{"given":"Kassahun","family":"Habtamu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyene","family":"Petros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"185_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04250-2","volume":"21","author":"A Abate","year":"2022","unstructured":"Abate A, Bouyssou I, Mabilotte S, Doderer-Lang C, Dembele L, Menard D, Golassa L. Vivax malaria in Duffy-negative patients shows invariably low asexual parasitaemia: implication towards malaria control in Ethiopia. Malar J. 2022;21:1\u201310.","journal-title":"Malar J"},{"key":"185_CR2","doi-asserted-by":"publisher","first-page":"e1004628","DOI":"10.1371\/journal.ppat.1004628","volume":"11","author":"HM Abkallo","year":"2015","unstructured":"Abkallo HM, Tangena J-A, Tang J, Kobayashi N, Inoue M, Zoungrana A, Colegrave N, Culleton R. Within-host competition does not select for virulence in malaria parasites; studies with Plasmodium yoelii. PLoS Pathog. 2015;11:e1004628.","journal-title":"PLoS Pathog"},{"key":"185_CR3","doi-asserted-by":"publisher","first-page":"e1002299","DOI":"10.1371\/journal.pmed.1002299","volume":"14","author":"T Abreha","year":"2017","unstructured":"Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, Assef A, Kassa M, Chatfield MD, Landman KZ. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial. PLoS Med. 2017;14:e1002299.","journal-title":"PLoS Med"},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"e26623","DOI":"10.1371\/journal.pone.0026623","volume":"6","author":"P Acharya","year":"2011","unstructured":"Acharya P, Pallavi R, Chandran S, Dandavate V, Sayeed SK, Rochani A, Acharya J, Middha S, Kochar S, Kochar D. Clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One. 2011;6:e26623.","journal-title":"PLoS One"},{"issue":"9","key":"185_CR5","doi-asserted-by":"publisher","first-page":"a025585","DOI":"10.1101\/cshperspect.a025585","volume":"7","author":"JH Adams","year":"2017","unstructured":"Adams JH, Mueller I. The biology of Plasmodium vivax. Cold Spring Harb Perspect Med. 2017;7(9):a025585.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"185_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12918-018-0669-4","volume":"13","author":"SR Adapa","year":"2019","unstructured":"Adapa SR, Taylor RA, Wang C, Thomson-Luque R, Johnson LR, Jiang RHY. Plasmodium vivax readiness to transmit: implication for malaria eradication. BMC Syst Biol. 2019;13:5.","journal-title":"BMC Syst Biol"},{"issue":"12","key":"185_CR7","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/diagnostics11122222","volume":"11","author":"S Aggarwal","year":"2021","unstructured":"Aggarwal S, Peng WK, Srivastava S. Multi-omics advancements towards Plasmodium vivax malaria diagnosis. Diagnostics (Basel). 2021;11(12):2222.","journal-title":"Diagnostics (Basel)"},{"key":"185_CR8","doi-asserted-by":"publisher","first-page":"e004558","DOI":"10.1136\/bmjgh-2020-004558","volume":"6","author":"SS Ahmad","year":"2021","unstructured":"Ahmad SS, Rahi M, Sharma A. Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India? BMJ Glob Health. 2021;6:e004558.","journal-title":"BMJ Glob Health"},{"key":"185_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-018-2787-7","volume":"11","author":"AC Almeida","year":"2018","unstructured":"Almeida AC, Kuehn A, Castro AJ, Vitor-Silva S, Figueiredo EF, Brasil LW, Brito MA, Sampaio VS, Bassat Q, Felger I. High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon. Parasit Vectors. 2018;11:1\u201313.","journal-title":"Parasit Vectors"},{"key":"185_CR10","doi-asserted-by":"publisher","first-page":"e0009077","DOI":"10.1371\/journal.pntd.0009077","volume":"15","author":"GG Almeida","year":"2021","unstructured":"Almeida GG, Costa PAC, Araujo MdS, Gomes GR, Carvalho AF, Figueiredo MM, Pereira DB, Tada MS, Medeiros JF, Soares IdS. Asymptomatic Plasmodium vivax malaria in the Brazilian Amazon: Submicroscopic parasitemic blood infects Nyssorhynchus darlingi. PLoS Neglected Trop Dis. 2021;15:e0009077.","journal-title":"PLoS Neglected Trop Dis"},{"key":"185_CR11","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.parint.2021.102526","volume":"87","author":"F Angrisano","year":"2022","unstructured":"Angrisano F, Robinson LJ. Plasmodium vivax\u2013How hidden reservoirs hinder global malaria elimination. Parasitol Int. 2022;87:102526.","journal-title":"Parasitol Int"},{"key":"185_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10025-6","volume":"7","author":"G Ar\u00e9valo-Pinz\u00f3n","year":"2017","unstructured":"Ar\u00e9valo-Pinz\u00f3n G, Berm\u00fadez M, Hern\u00e1ndez D, Curtidor H, Patarroyo MA. Plasmodium vivax ligand-receptor interaction: PvAMA-1 domain I contains the minimal regions for specific interaction with CD71+ reticulocytes. Sci Rep. 2017;7:1\u201313.","journal-title":"Sci Rep"},{"key":"185_CR13","doi-asserted-by":"publisher","first-page":"e2506","DOI":"10.1371\/journal.pntd.0002506","volume":"7","author":"A Arnott","year":"2013","unstructured":"Arnott A, Mueller I, Ramsland PA, Siba PM, Reeder JC, Barry AE. Global population structure of the genes encoding the malaria vaccine candidate, Plasmodium vivax apical membrane antigen 1 (Pv AMA1). PLoS Negl Trop Dis. 2013;7:e2506.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/RMHP.S219294","volume":"14","author":"N Arora","year":"2021","unstructured":"Arora N, Anbalagan LC, Pannu AK. Towards eradication of malaria: is the WHO\u2019s RTS, S\/AS01 vaccination effective enough? Risk Manag Healthcare Policy. 2021;14:1033.","journal-title":"Risk Manag Healthcare Policy"},{"key":"185_CR15","volume-title":"Challenges in the Control and Elimination of Plasmodium vivax Malaria. In Towards Malaria Elimination-A Leap Forward (IntechOpen)","author":"PB Asih","year":"2018","unstructured":"Asih PB, Syafruddin D, Baird JK. Challenges in the control and elimination of Plasmodium vivax malaria. In: Towards malaria elimination-A leap forward. IntechOpen; 2018."},{"key":"185_CR16","doi-asserted-by":"publisher","first-page":"5665660","DOI":"10.1155\/2022\/5665660","volume":"2022","author":"A Assemie","year":"2022","unstructured":"Assemie A. Malaria prevalence and distribution of plasmodium species in Southern Region of Ethiopia. J Parasitol Res. 2022;2022:5665660.","journal-title":"J Parasitol Res"},{"key":"185_CR17","doi-asserted-by":"publisher","first-page":"e1003560","DOI":"10.1371\/journal.pmed.1003560","volume":"18","author":"S Auburn","year":"2021","unstructured":"Auburn S, Cheng Q, Marfurt J, Price RN. The changing epidemiology of Plasmodium vivax: insights from conventional and novel surveillance tools. PLoS Med. 2021;18:e1003560.","journal-title":"PLoS Med"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/infdis\/jiz016","volume":"220","author":"S Auburn","year":"2019","unstructured":"Auburn S, Getachew S, Pearson RD, Amato R, Miotto O, Trimarsanto H, Zhu SJ, Rumaseb A, Marfurt J, Noviyanti R, et al. Genomic analysis of Plasmodium vivax in Southern Ethiopia reveals selective pressures in multiple parasite mechanisms. J Infect Dis. 2019;220:1738\u201349.","journal-title":"J Infect Dis"},{"key":"185_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s41182-021-00379-z","volume":"49","author":"AO Badmos","year":"2021","unstructured":"Badmos AO, Alaran AJ, Adebisi YA, Bouaddi O, Onibon Z, Dada A, Lin X, Lucero-Prisno DE. What sub-Saharan African countries can learn from malaria elimination in China. Trop Med Health. 2021;49:86.","journal-title":"Trop Med Health"},{"key":"185_CR20","doi-asserted-by":"publisher","unstructured":"Baird JK. 8-Aminoquinoline therapy for latent malaria. Clin Microbiol Rev. 2019 Jul 31;32(4):e00011\u201319. https:\/\/doi.org\/10.1128\/CMR.00011-19. PMID: 31366609; PMCID: PMC6750137.","DOI":"10.1128\/CMR.00011-19"},{"key":"185_CR21","doi-asserted-by":"crossref","unstructured":"Baird, J.K. (2022). African Plasmodium vivax malaria improbably rare or benign. Trends in Parasitology.","DOI":"10.1016\/j.pt.2022.05.006"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4269\/ajtmh.16-0171","volume":"95","author":"JK Baird","year":"2016","unstructured":"Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and treatment of Plasmodium vivax malaria. Am J Trop Med Hyg. 2016;95:35\u201351.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"102497","DOI":"10.1016\/j.parint.2021.102497","volume":"87","author":"S Bantuchai","year":"2022","unstructured":"Bantuchai S, Imad H, Nguitragool W. Plasmodium vivax gametocytes and transmission. Parasitol Int. 2022;87:102497.","journal-title":"Parasitol Int"},{"key":"185_CR24","doi-asserted-by":"crossref","unstructured":"Barber BE, Rajahram GS, Grigg MJ, William T, Anstey NM. World Malaria Report: time to acknowledge Plasmodium knowlesi malaria. Malar J. 2017;6:1\u20133.","DOI":"10.1186\/s12936-017-1787-y"},{"key":"185_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4269\/ajtmh.16-0180","volume":"95","author":"Q Bassat","year":"2016","unstructured":"Bassat Q, Velarde M, Mueller I, Lin J, Leslie T, Wongsrichanalai C, Baird JK. Key knowledge gaps for Plasmodium vivax control and elimination. Am J Trop Med Hyg. 2016;95:62.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamem.2010.08.009","volume":"1808","author":"LG Basso","year":"2011","unstructured":"Basso LG, Rodrigues RZ, Naal RM, Costa-Filho AJ. Effects of the antimalarial drug primaquine on the dynamic structure of lipid model membranes. Biochim Biophys Acta. 2011;1808:55\u201364.","journal-title":"Biochim Biophys Acta"},{"key":"185_CR27","doi-asserted-by":"publisher","first-page":"e1003799","DOI":"10.1371\/journal.pmed.1003799","volume":"18","author":"KE Battle","year":"2021","unstructured":"Battle KE, Baird JK. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med. 2021;18:e1003799.","journal-title":"PLoS Med"},{"key":"185_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep01300","volume":"3","author":"JI Blanford","year":"2013","unstructured":"Blanford JI, Blanford S, Crane RG, Mann ME, Paaijmans KP, Schreiber KV, Thomas MB. Implications of temperature variation for malaria parasite development across Africa. Sci Rep. 2013;3:1\u201311.","journal-title":"Sci Rep"},{"key":"185_CR29","doi-asserted-by":"crossref","unstructured":"Edith Christiane B, Sodiomon Bienvenu S. Inherited disorders of hemoglobin and Plasmodium falciparum malaria. In: Osaro E, Anjana M, editors. Human blood group systems and haemoglobinopathies. Rijeka: IntechOpen: 2020. p. Ch. 1.","DOI":"10.5772\/intechopen.93807"},{"key":"185_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fcimb.2018.00034","volume":"8","author":"C Bourgard","year":"2018","unstructured":"Bourgard C, Albrecht L, Kayano A, Sunnerhagen P, Costa FTM. Plasmodium vivax biology: insights provided by genomics, transcriptomics and proteomics. Front Cell Infect Microbiol. 2018;8:34.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR31","doi-asserted-by":"publisher","first-page":"346853","DOI":"10.1155\/2015\/346853","volume":"2015","author":"CB Braga","year":"2015","unstructured":"Braga CB, Martins AC, Cayotopa AD, Klein WW, Schlosser AR, da Silva AF, de Souza MN, Andrade BW, Filgueira-J\u00fanior JA, Pinto Wde J, et al. Side effects of chloroquine and primaquine and symptom reduction in malaria endemic area (M\u00e2ncio Lima, Acre, Brazil). Interdiscip Perspect Infect Dis. 2015;2015:346853.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"618430","DOI":"10.3389\/fcimb.2020.618430","volume":"10","author":"S Briquet","year":"2020","unstructured":"Briquet S, Marinach C, Silvie O, Vaquero C. Preparing for transmission: gene regulation in plasmodium sporozoites. Front Cell Infect Microbiol. 2020;10:618430.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/tropicalmed6020046","volume":"6","author":"A Bykersma","year":"2021","unstructured":"Bykersma A. The new zoonotic malaria: Plasmodium cynomolgi. Trop Med Infect Dis. 2021;6:46.","journal-title":"Trop Med Infect Dis"},{"issue":"6","key":"185_CR34","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.3390\/ijerph19063544","volume":"19","author":"E Bylicka-Szczepanowska","year":"2022","unstructured":"Bylicka-Szczepanowska E, Korzeniewski K. Asymptomatic malaria infections in the time of COVID-19 Pandemic: experience from the Central African Republic. Int J Environ Res Public Health. 2022;19(6):3544.","journal-title":"Int J Environ Res Public Health"},{"key":"185_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-11239-0","volume":"10","author":"G Camarda","year":"2019","unstructured":"Camarda G, Jirawatcharadech P, Priestley RS, Saif A, March S, Wong MH, Leung S, Miller AB, Baker DA, Alano P. Antimalarial activity of primaquine operates via a two-step biochemical relay. Nat Commun. 2019;10:1\u20139.","journal-title":"Nat Commun"},{"key":"185_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fgene.2018.00372","volume":"9","author":"PA Camargo-Ayala","year":"2018","unstructured":"Camargo-Ayala PA, Garz\u00f3n-Ospina D, Moreno-P\u00e9rez DA, Ricaurte-Contreras LA, Noya O, Patarroyo MA. On the evolution and function of Plasmodium vivax reticulocyte binding surface antigen (pvrbsa). Front Genet. 2018;9:372.","journal-title":"Front Genet"},{"key":"185_CR37","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/ijms20225748","volume":"20","author":"R Capela","year":"2019","unstructured":"Capela R, Moreira R, Lopes F. An overview of drug resistance in protozoal diseases. Int J Mol Sci. 2019;20:5748.","journal-title":"Int J Mol Sci"},{"key":"185_CR38","first-page":"93","volume":"2","author":"A Caputo","year":"2016","unstructured":"Caputo A, Garavelli PL. Climate, environment and transmission of malaria. Infez Med. 2016;2:93\u2013104.","journal-title":"Infez Med"},{"key":"185_CR39","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1086\/654815","volume":"202","author":"BO Carvalho","year":"2010","unstructured":"Carvalho BO, Lopes SC, Nogueira PA, Orlandi PP, Bargieri DY, Blanco YC, Mamoni R, Leite JA, Rodrigues MM, Soares IS. On the cytoadhesion of Plasmodium vivax\u2013infected erythrocytes. J Infect Dis. 2010;202:638\u201347.","journal-title":"J Infect Dis"},{"key":"185_CR40","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1111\/cmi.13110","volume":"22","author":"LJ Chan","year":"2020","unstructured":"Chan LJ, Dietrich MH, Nguitragool W, Tham WH. Plasmodium vivax Reticulocyte Binding Proteins for invasion into reticulocytes. Cell Microbiol. 2020;22:e13110.","journal-title":"Cell Microbiol"},{"key":"185_CR41","doi-asserted-by":"publisher","first-page":"e1003561","DOI":"10.1371\/journal.pmed.1003561","volume":"18","author":"CS Chu","year":"2021","unstructured":"Chu CS, White NJ. The prevention and treatment of Plasmodium vivax malaria. PLoS Med. 2021;18:e1003561.","journal-title":"PLoS Med"},{"key":"185_CR42","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41467-021-21886-x","volume":"12","author":"MA Clark","year":"2021","unstructured":"Clark MA, Kanjee U, Rangel GW, Chery L, Mascarenhas A, Gomes E, Rathod PK, Brugnara C, Ferreira MU, Duraisingh MT. Plasmodium vivax infection compromises reticulocyte stability. Nat Commun. 2021;12:1629.","journal-title":"Nat Commun"},{"key":"185_CR43","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","volume":"18","author":"RJ Commons","year":"2018","unstructured":"Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, A\u00f1ez A, Anstey NM, Awab GR, Baird JK. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018;18:1025\u201334.","journal-title":"Lancet Infect Dis"},{"key":"185_CR44","doi-asserted-by":"crossref","unstructured":"Conn JE, Grillet, ME, Correa M, Sallum MAM. (2018). Malaria transmission in South America\u2014present status and prospects for elimination. Towards malaria elimination\u2014a leap forward London: InTech, 281\u2013313.","DOI":"10.5772\/intechopen.76964"},{"key":"185_CR45","doi-asserted-by":"publisher","first-page":"e0008526","DOI":"10.1371\/journal.pntd.0008526","volume":"14","author":"RM Corder","year":"2020","unstructured":"Corder RM, de Lima AC, Khoury DS, Docken SS, Davenport MP, Ferreira MU. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: an observational and modeling study in Brazil. PLoS Negl Trop Dis. 2020;14:e0008526.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR46","doi-asserted-by":"publisher","unstructured":"Cui L, et al.\u00a0Elimination of Plasmodium vivax malaria: problems and solutions. In: Rodriguez-Morales AJ, editor. Current topics and emerging issues in malaria elimination. London: IntechOpen; 2021. https:\/\/doi.org\/10.5772\/intechopen.96604.","DOI":"10.5772\/intechopen.96604"},{"key":"185_CR47","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1016\/S2214-109X(21)00498-8","volume":"9","author":"J D'Souza","year":"2021","unstructured":"D\u2019Souza J, Nderitu D. Ethical considerations for introducing RTS, S\/AS01 in countries with moderate to high Plasmodium falciparum malaria transmission. Lancet Glob Health. 2021;9:e1642\u20133.","journal-title":"Lancet Glob Health"},{"key":"185_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1179\/2047773215Y.0000000014","volume":"109","author":"RF Daniels","year":"2015","unstructured":"Daniels RF, Rice BL, Daniels NM, Volkman SK, Hartl DL. The utility of genomic data for Plasmodium vivax population surveillance. Pathogens Global Health. 2015;109:153\u201361.","journal-title":"Pathogens Global Health"},{"key":"185_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/imr.12828","volume":"293","author":"RM de Jong","year":"2020","unstructured":"de Jong RM, Tebeje SK, Meerstein-Kessel L, Tadesse FG, Jore MM, Stone W, Bousema T. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites. Immunol Rev. 2020;293:190\u2013215.","journal-title":"Immunol Rev"},{"key":"185_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-021-03869-x","volume":"20","author":"A de Pina-Costa","year":"2021","unstructured":"de Pina-Costa A, Silvino ACR, Dos Santos EM, Pedro RS, Moreira J, Umana GL, da Silva ADT, da Rosa Santos OHL, de Deus Henriques KM, Daniel-Ribeiro CT. Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases. Malar J. 2021;20:1\u20136.","journal-title":"Malar J"},{"key":"185_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/14760584.2021.1880898","volume":"20","author":"SL De","year":"2021","unstructured":"De SL, Ntumngia FB, Nicholas J, Adams JH. Progress towards the development of a Plasmodium vivax vaccine. Expert Rev Vaccines. 2021;20:97\u2013112.","journal-title":"Expert Rev Vaccines"},{"key":"185_CR52","doi-asserted-by":"publisher","first-page":"e0005602","DOI":"10.1371\/journal.pntd.0005602","volume":"11","author":"A Devine","year":"2017","unstructured":"Devine A, Parmiter M, Chu CS, Bancone G, Nosten F, Price RN, Lubell Y, Yeung S. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: a cost-effectiveness analysis. PLoS Negl Trop Dis. 2017;11:e0005602.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR53","doi-asserted-by":"publisher","first-page":"e0177134","DOI":"10.1371\/journal.pone.0177134","volume":"12","author":"E Diez Benavente","year":"2017","unstructured":"Diez Benavente E, Ward Z, Chan W, Mohareb FR, Sutherland CJ, Roper C, Campino S, Clark TG. Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure. PLoS One. 2017;12:e0177134.","journal-title":"PLoS One"},{"key":"185_CR54","doi-asserted-by":"publisher","first-page":"e0005516","DOI":"10.1371\/journal.pntd.0005516","volume":"11","author":"XC Ding","year":"2017","unstructured":"Ding XC, Ade MP, Baird JK, Cheng Q, Cunningham J, Dhorda M, Drakeley C, Felger I, Gamboa D, Harbers M. Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: target product profiles. PLoS Negl Trop Dis. 2017;11:e0005516.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, Carter N, Cheng Q, Culpepper J, Eziefula C, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J"},{"key":"185_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","volume":"10","author":"NM Douglas","year":"2010","unstructured":"Douglas NM, Anstey NM, Angus BJ, Nosten F, Price RN. Artemisinin combination therapy for vivax malaria. Lancet Infect Dis. 2010;10:405\u201316.","journal-title":"Lancet Infect Dis"},{"key":"185_CR57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/s13071-016-1692-1","volume":"9","author":"NO Duah","year":"2016","unstructured":"Duah NO, Matrevi SA, Quashie NB, Abuaku B, Koram KA. Genetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decade. Parasit Vectors. 2016;9:416.","journal-title":"Parasit Vectors"},{"key":"185_CR58","doi-asserted-by":"crossref","unstructured":"Duffy PE, Acharya P, Oleinikov AV. (2014). Journal: Encyclopedia of Malaria, 2014, 1\u201313. Journal: Encyclopedia of Malaria, 1\u201313.","DOI":"10.1007\/978-1-4614-8757-9_39-1"},{"key":"185_CR59","doi-asserted-by":"crossref","unstructured":"Durnez L, Coosemans M. Residual transmission of malaria: an old issue for new approaches. In: Anopheles mosquitoes: new insights into malaria vectors\/Manguin, Sylvie; 2013. p. 671\u2013704.","DOI":"10.5772\/55925"},{"key":"185_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03743-w","volume":"20","author":"N Engel","year":"2021","unstructured":"Engel N, Ghergu C, Matin MA, Kibria MG, Thriemer K, Price RN, Ding XC, Howes RE, Ley B, Incardona S. Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh. Malar J. 2021;20:1\u201312.","journal-title":"Malar J"},{"key":"185_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04130-9","volume":"21","author":"AA Escalante","year":"2022","unstructured":"Escalante AA, Cepeda AS, Pacheco MA. Why Plasmodium vivax and Plasmodium falciparum are so different? A tale of two clades and their species diversities. Malar J. 2022;21:1\u201319.","journal-title":"Malar J"},{"key":"185_CR62","doi-asserted-by":"publisher","first-page":"13056","DOI":"10.1073\/pnas.1920596117","volume":"117","author":"C Fernandez-Becerra","year":"2020","unstructured":"Fernandez-Becerra C, Bernabeu M, Castellanos A, Correa BR, Obadia T, Ramirez M, Rui E, Hentzschel F, L\u00f3pez-Monta\u00f1\u00e9s M, Ayllon-Hermida A. Plasmodium vivax spleen-dependent genes encode antigens associated with cytoadhesion and clinical protection. Proc Natl Acad Sci. 2020;117:13056\u201365.","journal-title":"Proc Natl Acad Sci"},{"key":"185_CR63","doi-asserted-by":"publisher","first-page":"100169","DOI":"10.1016\/j.lana.2021.100169","volume":"9","author":"MU Ferreira","year":"2022","unstructured":"Ferreira MU, Corder RM, Johansen IC, Kattenberg JH, Moreno M, Rosas-Aguirre A, Ladeia-Andrade S, Conn JE, Llanos-Cuentas A, Gamboa D. Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys. Lancet Regional Health-Americas. 2022;9:100169.","journal-title":"Lancet Regional Health-Americas"},{"key":"185_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1179\/2047772415Z.000000000263","volume":"109","author":"MU Ferreira","year":"2015","unstructured":"Ferreira MU, de Oliveira TC. Challenges for Plasmodium vivax malaria elimination in the genomics era. Pathogens Glob Health. 2015;109:89\u201390.","journal-title":"Pathogens Glob Health"},{"key":"185_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4269\/ajtmh.21-1272","volume":"107","author":"MU Ferreira","year":"2022","unstructured":"Ferreira MU, Gamboa D, Torres K, Rodriguez-Ferrucci H, Soto-Calle VE, Pardo K, Fontoura PS, Tomko SS, Gazzinelli RT, Conn JE. Evidence-based malaria control and elimination in the Amazon: input from the International Center of excellence in malaria research network in Peru and Brazil. Am J Trop Med Hyg. 2022;107:160\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpddr.2020.12.001","volume":"15","author":"MU Ferreira","year":"2021","unstructured":"Ferreira MU, Nobrega de Sousa T, Rangel GW, Johansen IC, Corder RM, Ladeia-Andrade S, Gil JP. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions. Int J Parasitol Drugs Drug Resist. 2021;15:9\u201324.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"185_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12936-019-2827-6","volume":"18","author":"T File","year":"2019","unstructured":"File T, Dinka H, Golassa L. A retrospective analysis on the transmission of Plasmodium falciparum and Plasmodium vivax: the case of Adama City, East Shoa Zone, Oromia. Ethiopia Malaria Journal. 2019;18:193.","journal-title":"Ethiopia Malaria Journal"},{"key":"185_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03539-4","volume":"20","author":"M Finney","year":"2021","unstructured":"Finney M, McKenzie BA, Rabaovola B, Sutcliffe A, Dotson E, Zohdy S. Widespread zoophagy and detection of Plasmodium spp. in Anopheles mosquitoes in southeastern Madagascar. Malar J. 2021;20:1\u201312.","journal-title":"Malar J"},{"key":"185_CR69","doi-asserted-by":"publisher","first-page":"101815","DOI":"10.1016\/j.tmaid.2020.101815","volume":"36","author":"L Fischer","year":"2020","unstructured":"Fischer L, G\u00fcltekin N, Kaelin MB, Fehr J, Schlagenhauf P. Rising temperature and its impact on receptivity to malaria transmission in Europe: a systematic review. Travel Med Infect Dis. 2020;36:101815.","journal-title":"Travel Med Infect Dis"},{"key":"185_CR70","doi-asserted-by":"publisher","first-page":"e0005221","DOI":"10.1371\/journal.pntd.0005221","volume":"10","author":"PS Fontoura","year":"2016","unstructured":"Fontoura PS, Finco BF, Lima NF, de Carvalho Jr JF, Vinetz JM, Castro MC, Ferreira MU. Reactive case detection for Plasmodium vivax malaria elimination in rural Amazonia. PLoS Negl Trop Dis. 2016;10:e0005221.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12936-021-03790-3","volume":"20","author":"T Gari","year":"2021","unstructured":"Gari T, Solomon T, Lindtj\u00f8rn B. Older children are at increased risk of Plasmodium vivax in south-central Ethiopia: a cohort study. Malar J. 2021;20:251.","journal-title":"Malar J"},{"key":"185_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fgene.2018.00010","volume":"9","author":"D Garz\u00f3n-Ospina","year":"2018","unstructured":"Garz\u00f3n-Ospina D, Buitrago SP, Ramos AE, Patarroyo MA. Identifying potential Plasmodium vivax sporozoite stage vaccine candidates: an analysis of genetic diversity and natural selection. Front Genet. 2018;9:10.","journal-title":"Front Genet"},{"key":"185_CR73","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/cid\/ciy235","volume":"67","author":"ME Gilder","year":"2018","unstructured":"Gilder ME, Hanpithakphong W, Hoglund RM, Tarning J, Win HH, Hilda N, Chu CS, Bancone G, Carrara VI, Singhasivanon P, et al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin Infect Dis. 2018;67:1000\u20137.","journal-title":"Clin Infect Dis"},{"key":"185_CR74","doi-asserted-by":"crossref","unstructured":"Giovanella F, Ferreira GK, PR\u00c1 SDD, Carvalho-Silva M, Gomes LM, Scaini G, Goncalves RC, Michels M, Galant LS, Longaretti LM. Effects of primaquine and chloroquine on oxidative stress parameters in rats. An Acad Bras Cienc. 2015;87:1487\u201396.","DOI":"10.1590\/0001-3765201520140637"},{"key":"185_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03372-9","volume":"19","author":"L Golassa","year":"2020","unstructured":"Golassa L, Amenga-Etego L, Lo E, Amambua-Ngwa A. The biology of unconventional invasion of Duffy-negative reticulocytes by Plasmodium vivax and its implication in malaria epidemiology and public health. Malar J. 2020;19:1\u201310.","journal-title":"Malar J"},{"key":"185_CR76","first-page":"29","volume":"4","author":"G Gopi","year":"2019","unstructured":"Gopi G, Behera SM, Behera P. Tafenoquine: a breakthrough drug for radical cure and elimination of Malaria. Exploratory Res Hypothesis Med. 2019;4:29\u201334.","journal-title":"Exploratory Res Hypothesis Med"},{"key":"185_CR77","doi-asserted-by":"publisher","first-page":"e0008211","DOI":"10.1371\/journal.pntd.0008211","volume":"15","author":"ME Grillet","year":"2021","unstructured":"Grillet ME, Moreno JE, Hern\u00e1ndez-Villena JV, Vincenti-Gonz\u00e1lez MF, Noya O, Tami A, Paniz-Mondolfi A, Llewellyn M, Lowe R, Escalante AA. Malaria in Southern Venezuela: the hottest hotspot in Latin America. PLoS Negl Trop Dis. 2021;15:e0008211.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR78","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fmicb.2018.01271","volume":"9","author":"M Gualdr\u00f3n-L\u00f3pez","year":"2018","unstructured":"Gualdr\u00f3n-L\u00f3pez M, Flannery EL, Kangwanrangsan N, Chuenchob V, Fernandez-Orth D, Segui-Barber J, Royo F, Falc\u00f3n-P\u00e9rez JM, Fernandez-Becerra C, Lacerda MV. Characterization of Plasmodium vivax proteins in plasma-derived exosomes from malaria-infected liver-chimeric humanized mice. Front Microbiol. 2018;9:1271.","journal-title":"Front Microbiol"},{"key":"185_CR79","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pt.2018.02.006","volume":"34","author":"K Gunalan","year":"2018","unstructured":"Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH. Plasmodium vivax infections of Duffy-negative erythrocytes: historically undetected or a recent adaptation? Trends Parasitol. 2018;34:420\u20139.","journal-title":"Trends Parasitol"},{"key":"185_CR80","doi-asserted-by":"publisher","first-page":"10511","DOI":"10.1038\/s41598-018-28757-4","volume":"8","author":"S Gupta","year":"2018","unstructured":"Gupta S, Singh S, Popovici J, Roesch C, Shakri AR, Guillotte-Blisnick M, Huon C, Menard D, Chitnis CE. Targeting a reticulocyte binding protein and Duffy binding protein to inhibit reticulocyte invasion by Plasmodium vivax. Sci Rep. 2018;8:10511.","journal-title":"Sci Rep"},{"issue":"395\u2013406","key":"185_CR81","first-page":"e394","volume":"23","author":"N Gural","year":"2018","unstructured":"Gural N, Mancio-Silva L, Miller AB, Galstian A, Butty VL, Levine SS, Patrapuvich R, Desai SP, Mikolajczak SA, Kappe SH. In vitro culture, drug sensitivity, and transcriptome of Plasmodium vivax hypnozoites. Cell Host Microbe. 2018;23(395\u2013406):e394.","journal-title":"Cell Host Microbe"},{"key":"185_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-12571-9","volume":"22","author":"W Haileselassie","year":"2022","unstructured":"Haileselassie W, Parker DM, Taye B, David RE, Zemene E, Lee M-C, Zhong D, Zhou G, Alemu T, Tadele G. Burden of malaria, impact of interventions and climate variability in Western Ethiopia: an area with large irrigation based farming. BMC Public Health. 2022;22:1\u201311.","journal-title":"BMC Public Health"},{"key":"185_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06573-y","volume":"21","author":"DH Haiyambo","year":"2021","unstructured":"Haiyambo DH, Aleksenko L, Mumbengegwi D, Bock R, Uusiku P, Malleret B, R\u00e9nia L, Quaye IK. Children with Plasmodium vivax infection previously observed in Namibia, were Duffy negative and carried a c. 136G> A mutation. BMC Infect Dis. 2021;21:1\u20136.","journal-title":"BMC Infect Dis"},{"key":"185_CR84","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00204-020-02939-4","volume":"95","author":"H Hammer","year":"2021","unstructured":"Hammer H, Schmidt F, Marx-Stoelting P, P\u00f6tz O, Braeuning A. Cross-species analysis of hepatic cytochrome P450 and transport protein expression. Arch Toxicol. 2021;95:117\u201333.","journal-title":"Arch Toxicol"},{"key":"185_CR85","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bcp.14474","volume":"88","author":"B Hanboonkunupakarn","year":"2022","unstructured":"Hanboonkunupakarn B, White NJ. Advances and roadblocks in the treatment of malaria. Br J Clin Pharmacol. 2022;88:374\u201382.","journal-title":"Br J Clin Pharmacol"},{"key":"185_CR86","doi-asserted-by":"publisher","first-page":"e0007596","DOI":"10.1371\/journal.pntd.0007596","volume":"13","author":"W-Q He","year":"2019","unstructured":"He W-Q, Karl S, White MT, Nguitragool W, Monteiro W, Kuehn A, Gruszczyk J, Fran\u00e7a CT, Sattabongkot J, Lacerda MV. Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against Plasmodium vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand. PLoS Negl Trop Dis. 2019;13:e0007596.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR87","first-page":"173","volume":"16","author":"A Heidari","year":"2021","unstructured":"Heidari A, Keshavarz H. The drug resistance of Plasmodium falciparum and Plasmodium vivax in Iran: a review article. Iran J Parasitol. 2021;16:173.","journal-title":"Iran J Parasitol"},{"key":"185_CR88","doi-asserted-by":"publisher","first-page":"e1002380","DOI":"10.1371\/journal.pbio.1002380","volume":"14","author":"J Hemingway","year":"2016","unstructured":"Hemingway J, Shretta R, Wells TN, Bell D, Djimd\u00e9 AA, Achee N, Qi G. Tools and strategies for malaria control and elimination: what do we need to achieve a grand convergence in malaria? PLoS Biol. 2016;14:e1002380.","journal-title":"PLoS Biol"},{"key":"185_CR89","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2147\/IDR.S151031","volume":"12","author":"AB Hounkpatin","year":"2019","unstructured":"Hounkpatin AB, Kreidenweiss A, Held J. Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data. Infect Drug Resist. 2019;12:553\u201370.","journal-title":"Infect Drug Resist"},{"key":"185_CR90","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","volume":"95","author":"RE Howes","year":"2016","unstructured":"Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI. Global Epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95:15\u201334.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12936-022-04084-y","volume":"21","author":"F Huang","year":"2022","unstructured":"Huang F, Li S, Tian P, Pu LJS, Cui Y, Liu H, Yang L, Bi DY. Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar. Malar J. 2022;21:66.","journal-title":"Malar J"},{"key":"185_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-04017-1","volume":"20","author":"JH Huber","year":"2021","unstructured":"Huber JH, Koepfli C, Espa\u00f1a G, Nekkab N, White MT, Alex Perkins T. How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites. Malar J. 2021;20:1\u201315.","journal-title":"Malar J"},{"key":"185_CR93","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40471-021-00266-5","volume":"8","author":"MM Ippolito","year":"2021","unstructured":"Ippolito MM, Moser KA, Kabuya J-BB, Cunningham C, Juliano JJ. Antimalarial drug resistance and implications for the WHO global technical strategy. Curr Epidemiol Rep. 2021;8:46\u201362.","journal-title":"Curr Epidemiol Rep"},{"key":"185_CR94","doi-asserted-by":"publisher","first-page":"e0003634","DOI":"10.1371\/journal.pntd.0003634","volume":"9","author":"C Jennison","year":"2015","unstructured":"Jennison C, Arnott A, Tessier N, Tavul L, Koepfli C, Felger I, Siba PM, Reeder JC, Bahlo M, Mueller I. Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations. PLoS Negl Trop Dis. 2015;9:e0003634.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR95","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mib.2018.10.002","volume":"46","author":"U Kanjee","year":"2018","unstructured":"Kanjee U, Rangel GW, Clark MA, Duraisingh MT. Molecular and cellular interactions defining the tropism of Plasmodium vivax for reticulocytes. Curr Opin Microbiol. 2018;46:109\u201315.","journal-title":"Curr Opin Microbiol"},{"key":"185_CR96","doi-asserted-by":"publisher","unstructured":"Kepple D, Ford A, Little E, Kolesar G, Abagero BR, Blackwell AN, De Silva Indrasekara S, Yewhalaw D, Lo E. From Genes to Biomarkers: Understanding the biology of malaria gametocytes and their detection. In: \u00c7al\u0131\u015fkan M, editor. Genetic polymorphisms - new insights [Internet]. London: IntechOpen; 2021 [cited 2022 Nov 30]. Available from: https:\/\/www.intechopen.com\/chapters\/78331. https:\/\/doi.org\/10.5772\/intechopen.99364.","DOI":"10.5772\/intechopen.99364"},{"key":"185_CR97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/microorganisms9010015","volume":"9","author":"D Kepple","year":"2021","unstructured":"Kepple D, Pestana K, Tomida J, Abebe A, Golassa L, Lo E. Alternative invasion mechanisms and host immune response to Plasmodium vivax malaria: trends and future directions. Microorganisms. 2021;9:15.","journal-title":"Microorganisms"},{"key":"185_CR98","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3347\/kjp.2022.60.1.15","volume":"60","author":"T Khammanee","year":"2022","unstructured":"Khammanee T, Sawangjaroen N, Buncherd H, Tun AW, Thanapongpichat S. Prevalence of Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency among malaria patients in Southern Thailand: 8 years retrospective study. Korean J Parasitol. 2022;60:15.","journal-title":"Korean J Parasitol"},{"key":"185_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/2224-3151.213793","volume":"6","author":"S Kitchakarn","year":"2017","unstructured":"Kitchakarn S, Lek D, Thol S, Hok C, Saejeng A, Huy R, Chinanonwait N, Thimasarn K, Wongsrichanalai C. Implementation of G6PD testing and primaquine for Plasmodium vivax radical cure: operational perspectives from Thailand and Cambodia. WHO South East Asia J Public Health. 2017;6:60\u20138.","journal-title":"WHO South East Asia J Public Health"},{"key":"185_CR100","doi-asserted-by":"publisher","first-page":"e0009672","DOI":"10.1371\/journal.pntd.0009672","volume":"15","author":"C Koepfli","year":"2021","unstructured":"Koepfli C, Nguitragool W, de Almeida ACG, Kuehn A, Waltmann A, Kattenberg E, Ome-Kaius M, Rarau P, Obadia T, Kazura J. Identification of the asymptomatic\u00a0 gametocyte reservoir under different transmission intensities. Plasmodium falciparum and Plasmodium vivaxoS Negl Trop Dis. 2021;15:e0009672.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR101","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax Malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med"},{"key":"185_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-85890-3","volume":"11","author":"GZ Laporta","year":"2021","unstructured":"Laporta GZ, Ilacqua RC, Bergo ES, Chaves LS, Rodovalho SR, Moresco GG, Figueira EA, Massad E, de Oliveira TM, Bickersmith SA. Malaria transmission in landscapes with varying deforestation levels and timelines in the Amazon: a longitudinal spatiotemporal study. Sci Rep. 2021;11:1\u201314.","journal-title":"Sci Rep"},{"key":"185_CR103","doi-asserted-by":"crossref","unstructured":"Larson B.\u00a0Origin of two most virulent agents of human malaria: Plasmodium falciparum and Plasmodium vivax. In: Fyson HK, editor. Malaria. Rijeka: IntechOpen; 2019. p. Ch. 1.","DOI":"10.5772\/intechopen.84481"},{"key":"185_CR104","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1586\/eri.13.45","volume":"11","author":"KA Lindblade","year":"2013","unstructured":"Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L. The silent threat: asymptomatic parasitemia and malaria transmission. Expert Rev Anti Infect Ther. 2013;11:623\u201339.","journal-title":"Expert Rev Anti Infect Ther."},{"key":"185_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-022-04131-8","volume":"21","author":"W-C Lee","year":"2022","unstructured":"Lee W-C, Cheong FW, Amir A, Lai MY, Tan JH, Phang WK, Shahari S, Lau Y-L. Plasmodium knowlesi: the game changer for malaria eradication. Malar J. 2022;21:1\u201324.","journal-title":"Malar J"},{"key":"185_CR106","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3389\/fimmu.2019.01444","volume":"10","author":"W-C Lee","year":"2019","unstructured":"Lee W-C, Russell B, R\u00e9nia L. Sticking for a cause: the falciparum malaria parasites cytoadherence paradigm. Front Immunol. 2019;10:1444.","journal-title":"Front Immunol"},{"key":"185_CR107","first-page":"100389","volume":"14","author":"MEP Lempang","year":"2022","unstructured":"Lempang MEP, Dewayanti FK, Syahrani L, Permana DH, Malaka R, Asih PBS, Syafruddin D. Primate malaria: an emerging challenge of zoonotic malaria in Indonesia. One Health (Amsterdam, Netherlands). 2022;14:100389.","journal-title":"One Health (Amsterdam, Netherlands)"},{"key":"185_CR108","doi-asserted-by":"publisher","first-page":"680136","DOI":"10.3389\/fcimb.2021.680136","volume":"11","author":"YW Leong","year":"2021","unstructured":"Leong YW, Lee EQH, R\u00e9nia L, Malleret B. Rodent malaria erythrocyte preference assessment by an Ex Vivo Tropism Assay. Front Cell Infect Microbiol. 2021;11:680136.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR109","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12936-017-1981-y","volume":"16","author":"B Ley","year":"2017","unstructured":"Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, Khan WA, Dysoley L, Qi G, Kheong CC, et al. Barriers to routine G6PD testing prior to treatment with Primaquine. Malar J. 2017;16:329.","journal-title":"Malar J"},{"key":"185_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-022-00442-3","volume":"50","author":"M Lingani","year":"2022","unstructured":"Lingani M, Zango SH, Val\u00e9a I, Sanou M, Ouoba S, Samadoulougou S, Robert A, Tinto H, Dramaix M, Donnen P. Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso. Trop Med Health. 2022;50:1\u20138.","journal-title":"Trop Med Health"},{"key":"185_CR111","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/14656566.2022.2058394","volume":"23","author":"A Llanos-Cuentas","year":"2022","unstructured":"Llanos-Cuentas A, Manrrique P, Rosas-Aguirre A, Herrera S, Hsiang MS. Tafenoquine for the treatment of Plasmodium vivax malaria. Expert Opin Pharmacother. 2022;23:759\u201368.","journal-title":"Expert Opin Pharmacother"},{"key":"185_CR112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijid.2021.05.009","volume":"108","author":"E Lo","year":"2021","unstructured":"Lo E, Russo G, Pestana K, Kepple D, Abagero BR, Dongho GBD, Gunalan K, Miller LH, Hamid MMA, Yewhalaw D. Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across Africa. Int J Infect Dis. 2021;108:63\u201371.","journal-title":"Int J Infect Dis"},{"key":"185_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2981-x","volume":"18","author":"E Lo","year":"2019","unstructured":"Lo E, Zhong D, Raya B, Pestana K, Koepfli C, Lee M-C, Yewhalaw D, Yan G. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia. Malar J. 2019;18:1\u201310.","journal-title":"Malar J"},{"key":"185_CR114","doi-asserted-by":"publisher","first-page":"e0121763","DOI":"10.1371\/journal.pone.0121763","volume":"10","author":"E Lo","year":"2015","unstructured":"Lo E, Zhou G, Oo W, Afrane Y, Githeko A, Yan G. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS One. 2015;10:e0121763.","journal-title":"PLoS One"},{"key":"185_CR115","doi-asserted-by":"publisher","first-page":"e0010541","DOI":"10.1371\/journal.pntd.0010541","volume":"16","author":"M Loeffel","year":"2022","unstructured":"Loeffel M, Ross A. The relative impact of interventions on sympatric Plasmodium vivax and Plasmodium falciparum malaria: A systematic review. PLoS Negl Trop Dis. 2022;16:e0010541.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR116","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/nyas.12708","volume":"1342","author":"Z Luo","year":"2015","unstructured":"Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015;1342:53\u201361.","journal-title":"Ann N Y Acad Sci"},{"key":"185_CR117","doi-asserted-by":"publisher","first-page":"064015","DOI":"10.1088\/1748-9326\/aa64e6","volume":"12","author":"B Lyon","year":"2017","unstructured":"Lyon B, Dinku T, Raman A, Thomson MC. Temperature suitability for malaria climbing the Ethiopian Highlands. Environ Res Lett. 2017;12:064015.","journal-title":"Environ Res Lett"},{"key":"185_CR118","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/IDR.S135897","volume":"11","author":"MS Mac Donald-Ottevanger","year":"2018","unstructured":"Mac Donald-Ottevanger MS, Adhin MR, Jitan JK, Bretas G, Vreden SG. Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname. Infect Drug Resist. 2018;11:3\u20138.","journal-title":"Infect Drug Resist"},{"key":"185_CR119","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1111\/bph.15651","volume":"178","author":"G Magliocco","year":"2021","unstructured":"Magliocco G, Desmeules J, Matthey A, Quir\u00f3s-Guerrero LM, Bararpour N, Joye T, Marcourt L, Queiroz EF, Wolfender JL, Gloor Y. Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity. Br J Pharmacol. 2021;178:4708\u201325.","journal-title":"Br J Pharmacol"},{"key":"185_CR120","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1182\/blood-2014-08-596015","volume":"125","author":"B Malleret","year":"2015","unstructured":"Malleret B, Li A, Zhang R, Tan KS, Suwanarusk R, Claser C, Cho JS, Koh EGL, Chu CS, Pukrittayakamee S. Plasmodium vivax: restricted tropism and rapid remodeling of CD71-positive reticulocytes. Blood. 2015;125:1314\u201324.","journal-title":"Blood"},{"key":"185_CR121","doi-asserted-by":"crossref","unstructured":"Malvy D, Torrentino-Madamet M, l'Ollivier C, Receveur M-C, Jeddi F, Delhaes L, Piarroux R, Millet P, Pradines B. Plasmodium falciparum recrudescence two years after treatment of an uncomplicated infection without return to an area where malaria is endemic. Antimicrob Agents Chemother. 2018;62:e01892\u201301817.","DOI":"10.1128\/AAC.01892-17"},{"key":"185_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2016.03.011","volume":"161","author":"SR Marcsisin","year":"2016","unstructured":"Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art. Pharmacol Ther. 2016;161:1\u201310.","journal-title":"Pharmacol Ther"},{"key":"185_CR123","doi-asserted-by":"publisher","first-page":"e2155","DOI":"10.1371\/journal.pntd.0002155","volume":"7","author":"A Mar\u00edn-Men\u00e9ndez","year":"2013","unstructured":"Mar\u00edn-Men\u00e9ndez A, Bardaj\u00ed A, Mart\u00ednez-Espinosa FE, B\u00f4tto-Menezes C, Lacerda MV, Ortiz J, Cister\u00f3 P, Piqueras M, Felger I, M\u00fceller I. Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis. 2013;7:e2155.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR124","doi-asserted-by":"publisher","first-page":"654054","DOI":"10.3389\/fphar.2021.654054","volume":"12","author":"RK Mehlotra","year":"2021","unstructured":"Mehlotra RK, Gaedigk A, Howes RE, Rakotomanga TA, Ratsimbasoa AC, Zimmerman PA. CYP2D6 genetic variation and its implication for vivax malaria treatment in Madagascar. Front Pharmacol. 2021;12:654054.","journal-title":"Front Pharmacol"},{"key":"185_CR125","unstructured":"Menkin-Smith L, Winders WT. Plasmodium Vivax Malaria. [Updated 2022 Jul 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538333\/."},{"key":"185_CR126","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","volume":"17","author":"SA Mikolajczak","year":"2015","unstructured":"Mikolajczak SA, Vaughan AM, Kangwanrangsan N, Roobsoong W, Fishbaugher M, Yimamnuaychok N, Rezakhani N, Lakshmanan V, Singh N, Kaushansky A. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe. 2015;17:526\u201335.","journal-title":"Cell Host Microbe"},{"key":"185_CR127","first-page":"2656","volume":"7","author":"R Milligan","year":"2019","unstructured":"Milligan R, Daher A, Graves PM. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2019;7:2656.","journal-title":"Cochrane Database Syst Rev"},{"key":"185_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/frym.2021.656168","volume-title":"What Is Genetic Diversity and Why Does it Matter?","author":"M Minter","year":"2021","unstructured":"Minter M, Nielsen ES, Blyth C, Bertola LD, Kantar MB, Morales HE, Orland C, Segelbacher G, Leigh DM. What is genetic diversity and why does it matter? 2021."},{"key":"185_CR129","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3390\/ijerph16050694","volume":"16","author":"V Mironova","year":"2019","unstructured":"Mironova V, Shartova N, Beljaev A, Varentsov M, Grishchenko M. Effects of climate change and heterogeneity of local climates on the development of malaria parasite (Plasmodium vivax) in Moscow megacity region. Int J Environ Res Public Health. 2019;16:694.","journal-title":"Int J Environ Res Public Health"},{"key":"185_CR130","unstructured":"Mitali M, Vikash Kumar M, Varsha K, Sushil Kumar K.\u00a0Molecular approaches for malaria therapy. In: Rajeev KT, editor. Plasmodium species and drug resistance. Rijeka: IntechOpen; 2021. p. Ch. 8."},{"key":"185_CR131","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12936-022-04178-7","volume":"21","author":"A Monroe","year":"2022","unstructured":"Monroe A, Williams NA, Ogoma S, Karema C, Okumu F. Reflections on the 2021 World Malaria Report and the future of malaria control. Malar J. 2022;21:154.","journal-title":"Malar J"},{"issue":"7","key":"185_CR132","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijpara.2019.02.007","volume":"49","author":"I Muller","year":"2019","unstructured":"Muller I, Jex AR, Kappe SH, Mikolajczak SA, Sattabongkot J, Patrapuvich R, Lindner S, Flannery EL, Koepfli C, Ansell B, Lerch A. Transcriptome and histone epigenome of Plasmodium vivax salivary-gland sporozoites point to tight regulatory control and mechanisms for liver-stage differentiation in relapsing malaria. Int J Parasitol. 2019;49(7):501\u201313.","journal-title":"Int J Parasitol."},{"key":"185_CR133","doi-asserted-by":"publisher","first-page":"e0233478","DOI":"10.1371\/journal.pone.0233478","volume":"15","author":"JL Myers-Hansen","year":"2020","unstructured":"Myers-Hansen JL, Abuaku B, Oyebola MK, Mensah BA, Ahorlu C, Wilson MD, Awandare G, Koram KA, Ngwa AA, Ghansah A. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana. PLoS One. 2020;15:e0233478.","journal-title":"PLoS One"},{"key":"185_CR134","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12936-022-04082-0","volume":"21","author":"C Naing","year":"2022","unstructured":"Naing C, Htet NH, Aye SN, Aung HH, Tanner M, Whittaker MA. Detection of asymptomatic malaria in Asian countries: a meta-analysis of diagnostic accuracy. Malar J. 2022;21:50.","journal-title":"Malar J"},{"key":"185_CR135","doi-asserted-by":"publisher","first-page":"100273","DOI":"10.1016\/j.lana.2022.100273","volume":"12","author":"JR Nascimento","year":"2022","unstructured":"Nascimento JR, Brito-Sousa JD, Almeida ACG, Melo MM, Costa MRF, Barbosa LRA, Ramos RN, Silva-Neto AV, da Silva Balieiro PC, Figueiredo EFG. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study. Lancet Regional Health-Americas. 2022;12:100273.","journal-title":"Lancet Regional Health-Americas"},{"key":"185_CR136","doi-asserted-by":"publisher","first-page":"e1003535","DOI":"10.1371\/journal.pmed.1003535","volume":"18","author":"N Nekkab","year":"2021","unstructured":"Nekkab N, Lana R, Lacerda M, Obadia T, Siqueira A, Monteiro W, Villela D, Mueller I, White M. Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study. PLoS Med. 2021;18:e1003535.","journal-title":"PLoS Med"},{"key":"185_CR137","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/femsre\/fuz010","volume":"43","author":"P Ngotho","year":"2019","unstructured":"Ngotho P, Soares AB, Hentzschel F, Achcar F, Bertuccini L, Marti M. Revisiting gametocyte biology in malaria parasites. FEMS Microbiol Rev. 2019;43:401\u201314.","journal-title":"FEMS Microbiol Rev"},{"key":"185_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-017-2407-y","volume":"10","author":"W Nguitragool","year":"2017","unstructured":"Nguitragool W, Mueller I, Kumpitak C, Saeseu T, Bantuchai S, Yorsaeng R, Yimsamran S, Maneeboonyang W, Sa-Angchai P, Chaimungkun W. Very high carriage of gametocytes in asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in western Thailand. Parasit Vectors. 2017;10:1\u20139.","journal-title":"Parasit Vectors"},{"key":"185_CR139","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12936-019-2903-y","volume":"18","author":"C Noisang","year":"2019","unstructured":"Noisang C, Prosser C, Meyer W, Chemoh W, Ellis J, Sawangjaroen N, Lee R. Molecular detection of drug resistant malaria in Southern Thailand. Malar J. 2019;18:275.","journal-title":"Malar J"},{"key":"185_CR140","doi-asserted-by":"crossref","unstructured":"Noviyanti R, Carey-Ewend K, Trianty L, Parobek C, Puspitasari AM, Balasubramanian S, Park Z, Hathaway N, Utami RA, Soebianto S. Hypnozoite depletion in successive Plasmodium vivax relapses. PLoS Neglect Trop Dis. 2022;16:e0010648.","DOI":"10.1371\/journal.pntd.0010648"},{"key":"185_CR141","doi-asserted-by":"publisher","unstructured":"Obaldia N 3rd, Meibalan E, Sa JM, Ma S, Clark MA, Mejia P, Moraes Barros RR, Otero W, Ferreira MU, Mitchell JR, Milner DA, Huttenhower C, Wirth DF, Duraisingh MT, Wellems TE, Marti M. Bone marrow is a major parasite reservoir in Plasmodium vivax Infection. mBio. 2018;9(3):e00625\u201318. https:\/\/doi.org\/10.1128\/mBio.00625-18.","DOI":"10.1128\/mBio.00625-18"},{"key":"185_CR142","doi-asserted-by":"publisher","first-page":"e0010327","DOI":"10.1371\/journal.pntd.0010327","volume":"16","author":"N Obald\u00eda","year":"2022","unstructured":"Obald\u00eda N, Barahona I, Lasso J, Avila M, Quijada M, Nu\u00f1ez M, Marti M. Comparison of PvLAP5 and Pvs25 qRT-PCR assays for the detection of Plasmodium vivax gametocytes in field samples preserved at ambient temperature from remote malaria endemic regions of Panama. PLoS Negl Trop Dis. 2022;16:e0010327.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR143","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3389\/fcimb.2021.786317","volume":"11","author":"CO Oduma","year":"2021","unstructured":"Oduma CO, Koepfli C. Plasmodium falciparum and Plasmodium vivax Adjust investment in transmission in response to change in transmission intensity: a review of the current state of research. Front Cellular Infect Microbiol. 2021;11:1237.","journal-title":"Front Cellular Infect Microbiol."},{"key":"185_CR144","doi-asserted-by":"publisher","first-page":"104366","DOI":"10.1016\/j.amsu.2022.104366","volume":"81","author":"HJ Oladipo","year":"2022","unstructured":"Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, AbdulBasit MO, Adebisi YA, El-Sherbini MS. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg. 2022;81:104366.","journal-title":"Ann Med Surg"},{"key":"185_CR145","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4269\/ajtmh.16-0160","volume":"95","author":"PL Olliaro","year":"2016","unstructured":"Olliaro PL, Barnwell JW, Barry A, Mendis K, Mueller I, Reeder JC, Shanks GD, Snounou G, Wongsrichanalai C. Implications of Plasmodium vivax biology for control, elimination, and research. Am J Trop Med Hyg. 2016;95:4\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-019-1456-9","volume":"17","author":"M Ome-Kaius","year":"2019","unstructured":"Ome-Kaius M, Kattenberg JH, Zaloumis S, Siba M, Kiniboro B, Jally S, Razook Z, Mantila D, Sui D, Ginny J. Differential impact of malaria control interventions on Plasmodium falciparum and Plasmodium vivax infections in young Papua New Guinean children. BMC Med. 2019;17:1\u201313.","journal-title":"BMC Med"},{"key":"185_CR147","doi-asserted-by":"publisher","unstructured":"Park JW. Changing Transmission Pattern of Plasmodium vivax malaria in the Republic of Korea: relationship with climate change. Environ Health Toxicol. 2011;26:e2011001. https:\/\/doi.org\/10.5620\/eht.2011.26.e2011001. Epub 2011 Mar 8.","DOI":"10.5620\/eht.2011.26.e2011001"},{"key":"185_CR148","doi-asserted-by":"publisher","first-page":"614122","DOI":"10.3389\/fcimb.2020.614122","volume":"10","author":"EM Pasini","year":"2021","unstructured":"Pasini EM, Kocken CH. Parasite-host interaction and pathophysiology studies of the human relapsing malarias Plasmodium vivax and Plasmodium ovale infections in non-human primates. Front Cell Infect Microbiol. 2021;10:614122.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR149","doi-asserted-by":"publisher","first-page":"e1700024","DOI":"10.1002\/prca.201700024","volume":"12","author":"S Patankar","year":"2018","unstructured":"Patankar S, Sharma S, Rathod PK, Duraisingh MT. Malaria in India: The need for new targets for diagnosis and detection of Plasmodium vivax. Proteomics Clin Appl. 2018;12:e1700024.","journal-title":"Proteomics Clin Appl"},{"key":"185_CR150","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-019-0973-1","volume":"567","author":"DG Paton","year":"2019","unstructured":"Paton DG, Childs LM, Itoe MA, Holmdahl IE, Buckee CO, Catteruccia F. Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission. Nature. 2019;567:239\u201343.","journal-title":"Nature"},{"key":"185_CR151","doi-asserted-by":"publisher","first-page":"e000176","DOI":"10.1136\/bmjgh-2016-000176","volume":"2","author":"E Patouillard","year":"2017","unstructured":"Patouillard E, Griffin J, Bhatt S, Ghani A, Cibulskis R. Global investment targets for malaria control and elimination between 2016 and 2030. BMJ Glob Health. 2017;2:e000176.","journal-title":"BMJ Glob Health"},{"key":"185_CR152","doi-asserted-by":"publisher","first-page":"e00538","DOI":"10.1128\/AAC.00538-19","volume":"63","author":"H Pett","year":"2019","unstructured":"Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gon\u00e7alves BP, Stone W, Chen I, Lanke K, Neuvonen M. CYP2D6 polymorphisms and the safety and gametocytocidal activity of single-dose primaquine for Plasmodium falciparum. Antimicrob Agents Chemother. 2019;63:e00538-e519.","journal-title":"Antimicrob Agents Chemother"},{"key":"185_CR153","unstructured":"Pham Vinh T.\u00a0Epidemiology of Plasmodium vivax malaria in Central Vietnam. UCL-Universit\u00e9 Catholique de Louvain; 2018."},{"key":"185_CR154","doi-asserted-by":"publisher","first-page":"e1003890","DOI":"10.1371\/journal.pmed.1003890","volume":"19","author":"AP Phyo","year":"2022","unstructured":"Phyo AP, Dahal P, Mayxay M, Ashley EA. Clinical impact of vivax malaria: a collection review. PLoS Med. 2022;19:e1003890.","journal-title":"PLoS Med"},{"key":"185_CR155","doi-asserted-by":"publisher","first-page":"e1008258","DOI":"10.1371\/journal.ppat.1008258","volume":"16","author":"J Popovici","year":"2020","unstructured":"Popovici J, Roesch C, Rougeron V. The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals. PLoS Pathog. 2020;16:e1008258.","journal-title":"PLoS Pathog"},{"key":"185_CR156","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1128\/AAC.00015-15","volume":"59","author":"BM Potter","year":"2015","unstructured":"Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, Luong T-LT, Bandara Herath H, Dhammika Nanayakkara N, Tekwani BL. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother. 2015;59:2380\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"185_CR157","doi-asserted-by":"publisher","first-page":"251","DOI":"10.11604\/pamj.2021.39.251.28996","volume":"39","author":"JK Prah","year":"2021","unstructured":"Prah JK, Amoah S, Yartey AN, Ampofo-Asiama A, Ameyaw EO. Assessment of malaria diagnostic methods and treatments at a Ghanaian health facility. Pan Afr Med J. 2021;39:251.","journal-title":"Pan Afr Med J"},{"key":"185_CR158","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking Plasmodium falciparum Map. Trends Parasitol. 2020;36:560\u201370.","journal-title":"Trends Parasitol"},{"key":"185_CR159","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking Plasmodium falciparum Map. Trends Parasitol. 2020;36:560\u201370.","journal-title":"Trends Parasitol"},{"key":"185_CR160","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982\u201391.","journal-title":"Lancet Infect Dis"},{"key":"185_CR161","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/microorganisms10061183","volume":"10","author":"T Rehn","year":"2022","unstructured":"Rehn T, Lubiana P, Nguyen THT, Pansegrau E, Schmitt M, Roth LK, Brehmer J, Roeder T, Cadar D, Metwally NG. Ectopic expression of Plasmodium vivax vir Genes in Plasmodium falciparum affects cytoadhesion via increased expression of specific var genes. Microorganisms. 2022;10:1183.","journal-title":"Microorganisms"},{"key":"185_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/20477724.2015.1133033","volume":"110","author":"K Rishikesh","year":"2016","unstructured":"Rishikesh K, Saravu K. Primaquine treatment and relapse in Plasmodium vivax malaria. Pathogens Global Health. 2016;110:1\u20138.","journal-title":"Pathogens Global Health"},{"key":"185_CR163","first-page":"10458","volume":"9","author":"C Rodrigo","year":"2020","unstructured":"Rodrigo C, Rajapakse S, Fernando D. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2020;9:10458.","journal-title":"Cochrane Database Syst Rev"},{"key":"185_CR164","doi-asserted-by":"publisher","first-page":"e20200179","DOI":"10.1590\/0037-8682-0179-2020","volume":"53","author":"JAI Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez JAI, Rodr\u00edguez SNI, Olivera MJ. Plasmodium vivax malaria across South America: management guidelines and their quality assessment. Rev Soc Bras Med Trop. 2020;53:e20200179.","journal-title":"Rev Soc Bras Med Trop"},{"key":"185_CR165","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.4269\/ajtmh.22-0128","volume":"106","author":"PJ Rosenthal","year":"2022","unstructured":"Rosenthal PJ. Malaria in 2022: Challenges and progress. Am J Trop Med Hyg. 2022;106:1565\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1722-2","volume":"16","author":"G Russo","year":"2017","unstructured":"Russo G, Faggioni G, Paganotti GM, Djeunang Dongho GB, Pomponi A, De Santis R, Tebano G, Mbida M, Sanou Sobze M, Vullo V. Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West Cameroon. Malar J. 2017;16:1\u20139.","journal-title":"Malar J"},{"key":"185_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40101-020-00251-9","volume":"40","author":"S Sato","year":"2021","unstructured":"Sato S. Plasmodium\u2014a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021;40:1.","journal-title":"J Physiol Anthropol"},{"key":"185_CR168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-021-03792-1","volume":"20","author":"MS Shaikh","year":"2021","unstructured":"Shaikh MS, Ali B, Janjua M, Akbar A, Haider SA, Moiz B, Raheem A, Baird JK, Beg MA. Plasmodium in the bone marrow: case series from a hospital in Pakistan, 2007\u20132015. Malar J. 2021;20:1\u20136.","journal-title":"Malar J"},{"key":"185_CR169","doi-asserted-by":"publisher","first-page":"e008431","DOI":"10.1136\/bmjgh-2022-008431","volume":"7","author":"S Sharma","year":"2022","unstructured":"Sharma S, Verma R, Yadav B, Kumar A, Rahi M, Sharma A. What India can learn from globally successful malaria elimination programmes. BMJ Glob Health. 2022;7:e008431.","journal-title":"BMJ Glob Health"},{"key":"185_CR170","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.3390\/ijerph19106195","volume":"19","author":"AM Soto","year":"2022","unstructured":"Soto AM, Gonz\u00e1lez-Cer\u00f3n L, Santill\u00e1n-Valenzuela F, Parrales ME, Montoya A. Recurrent Plasmodium vivax cases of both short and long latency increased with transmission intensity and were distributed year-round in the most affected municipalities of the RACCN, Nicaragua, 2013\u20132018. Int J Environ Res Public Health. 2022;19:6195.","journal-title":"Int J Environ Res Public Health"},{"key":"185_CR171","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4269\/ajtmh.20-0061","volume":"103","author":"MD Spring","year":"2020","unstructured":"Spring MD, Lon C, Sok S, Sea D, Wojnarski M, Chann S, Kuntawunginn W, Kheang Heng T, Nou S, Arsanok M, et al. Prevalence of CYP2D6 genotypes and predicted phenotypes in a cohort of Cambodians at high risk for infections with Plasmodium vivax. Am J Trop Med Hyg. 2020;103:756\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR172","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/infdis\/jiz386","volume":"220","author":"MD Spring","year":"2019","unstructured":"Spring MD, Sousa JC, Li Q, Darko CA, Morrison MN, Marcsisin SR, Mills KT, Potter BM, Paolino KM, Twomey PS, et al. Determination of cytochrome P450 isoenzyme 2D6 (CYP2D6) genotypes and pharmacogenomic impact on primaquine metabolism in an active-duty US military population. J Infect Dis. 2019;220:1761\u201370.","journal-title":"J Infect Dis"},{"key":"185_CR173","doi-asserted-by":"publisher","unstructured":"Stevens-Hernandez CJ, Flatt JF, Kupzig S, Bruce LJ. Reticulocyte maturation and variant red blood cells. Front Physiol. 2022;13:834463. https:\/\/doi.org\/10.3389\/fphys.2022.834463.","DOI":"10.3389\/fphys.2022.834463"},{"key":"185_CR174","doi-asserted-by":"publisher","first-page":"784909","DOI":"10.3389\/fphar.2021.784909","volume":"12","author":"AGA Stewart","year":"2021","unstructured":"Stewart AGA, Zimmerman PA, McCarthy JS. Genetic Variation of G6PD and CYP2D6: Clinical Implications on the use of primaquine for elimination of Plasmodium vivax. Front Pharmacol. 2021;12:784909.","journal-title":"Front Pharmacol"},{"key":"185_CR175","doi-asserted-by":"publisher","first-page":"e9164","DOI":"10.15252\/emmm.201809164","volume":"11","author":"J Storm","year":"2019","unstructured":"Storm J, Jespersen JS, Seydel KB, Szestak T, Mbewe M, Chisala NV, Phula P, Wang CW, Taylor TE, Moxon CA. Cerebral malaria is associated with differential cytoadherence to brain endothelial cells. EMBO Mol Med. 2019;11:e9164.","journal-title":"EMBO Mol Med"},{"key":"185_CR176","doi-asserted-by":"crossref","unstructured":"Styka AN, Savitz DA. 2020. Assessment of long-term health effects of antimalarial drugs when used for prophylaxis.","DOI":"10.17226\/25688"},{"key":"185_CR177","doi-asserted-by":"publisher","first-page":"587933","DOI":"10.3389\/fcimb.2020.587933","volume":"10","author":"X-Z Su","year":"2020","unstructured":"Su X-Z, Zhang C, Joy DA. Host-malaria parasite interactions and impacts on mutual evolution. Front Cell Infect Microbiol. 2020;10:587933.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR178","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1128\/AAC.01879-12","volume":"57","author":"I Sutanto","year":"2013","unstructured":"Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA, Setiabudy R, Nurleila S, Ekawati LL, Elyazar I. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother. 2013;57:1128\u201335.","journal-title":"Antimicrob Agents Chemother"},{"key":"185_CR179","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/genes11111295","volume":"11","author":"C Taylor","year":"2020","unstructured":"Taylor C, Crosby I, Yip V, Maguire P, Pirmohamed M, Turner RM. A review of the important role of CYP2D6 in pharmacogenomics. Genes. 2020;11:1295.","journal-title":"Genes"},{"key":"185_CR180","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/s41467-019-13412-x","volume":"10","author":"AR Taylor","year":"2019","unstructured":"Taylor AR, Watson JA, Chu CS, Puaprasert K, Duanguppama J, Day NPJ, Nosten F, Neafsey DE, Buckee CO, Imwong M, et al. Resolving the cause of recurrent Plasmodium vivax malaria probabilistically. Nat Commun. 2019;10:5595.","journal-title":"Nat Commun."},{"key":"185_CR181","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4269\/ajtmh.19-0890","volume":"103","author":"A Teklehaimanot","year":"2020","unstructured":"Teklehaimanot A, Teklehaimanot H, Girmay A, Woyessa A. Case report: primaquine failure for radical cure of Plasmodium vivax malaria in Gambella, Ethiopia. Am J Trop Med Hyg. 2020;103:415\u201320.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR182","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijpara.2016.09.006","volume":"47","author":"W-H Tham","year":"2017","unstructured":"Tham W-H, Beeson JG, Rayner JC. Plasmodium vivax vaccine research\u2013we\u2019ve only just begun. Int J Parasitol. 2017;47:111\u20138.","journal-title":"Int J Parasitol"},{"key":"185_CR183","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.actatropica.2016.04.009","volume":"160","author":"D Thomas","year":"2016","unstructured":"Thomas D, Tazerouni H, Sundararaj KGS, Cooper JC. Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax. Acta Trop. 2016;160:35\u20138.","journal-title":"Acta Trop"},{"key":"185_CR184","doi-asserted-by":"publisher","first-page":"675156","DOI":"10.3389\/fcimb.2021.675156","volume":"11","author":"R Thomson-Luque","year":"2021","unstructured":"Thomson-Luque R, Bautista JM. Home Sweet Home: Plasmodium vivax-infected reticulocytes-the younger the better? Front Cell Infect Microbiol. 2021;11:675156.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR185","volume-title":"Immature reticulocytes as preferential host cells and the challenges for in vitro culture of Plasmodium vivax","author":"R Thomson-Luque","year":"2015","unstructured":"Thomson-Luque R, Scopel KK. Immature reticulocytes as preferential host cells and the challenges for in vitro culture of Plasmodium vivax. Taylor & Francis; 2015."},{"key":"185_CR186","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.gendis.2017.09.001","volume":"4","author":"M Tiwari","year":"2017","unstructured":"Tiwari M. Glucose 6 phosphatase dehydrogenase (G6PD) and neurodegenerative disorders: mapping diagnostic and therapeutic opportunities. Genes Dis. 2017;4:196\u2013203.","journal-title":"Genes & diseases"},{"key":"185_CR187","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4269\/ajtmh.22-0127","volume":"107","author":"K Torres","year":"2022","unstructured":"Torres K, Ferreira MU, Castro MC, Escalante AA, Conn JE, Villasis E, da Silva Araujo M, Almeida G, Rodrigues PT, Corder RM. Malaria resilience in South America: epidemiology, vector biology, and immunology insights from the Amazonian International Center of excellence in malaria research network in Peru and Brazil. Am J Trop Med Hyg. 2022;107:168\u201381.","journal-title":"Am J Trop Med Hyg"},{"key":"185_CR188","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3389\/fimmu.2017.01148","volume":"8","author":"PR Totino","year":"2017","unstructured":"Totino PR, Lopes SC. Insights into the cytoadherence phenomenon of Plasmodium vivax: the putative role of phosphatidylserine. Front Immunol. 2017;8:1148.","journal-title":"Front Immunol"},{"key":"185_CR189","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12936-016-1104-1","volume":"15","author":"AF Vallejo","year":"2016","unstructured":"Vallejo AF, Garc\u00eda J, Amado-Garavito AB, Ar\u00e9valo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016;15:48.","journal-title":"Malar J"},{"key":"185_CR190","doi-asserted-by":"publisher","unstructured":"Vantaux A, P\u00e9neau J, Cooper CA, Kyle DE, Witkowski B, Maher SP. Liver stage fate determination in Plasmodium vivax parasites: characterization of schizont growth and hypnozoite fating from patient isolates. bioRxiv.\u00a02022.06.16.496373. https:\/\/doi.org\/10.1101\/2022.06.16.496373.","DOI":"10.1101\/2022.06.16.496373"},{"key":"185_CR191","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2666-5247(22)00070-2","volume":"3","author":"P Venkatesan","year":"2022","unstructured":"Venkatesan P. The future of malaria control in light of RTS. S The Lancet Microbe. 2022;3:e251.","journal-title":"S The Lancet Microbe"},{"key":"185_CR192","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","volume":"18","author":"K Venugopal","year":"2020","unstructured":"Venugopal K, Hentzschel F, Valki\u016bnas G, Marti M. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020;18:177\u201389.","journal-title":"Nat Rev Microbiol"},{"key":"185_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-016-1524-y","volume":"15","author":"A Verma","year":"2016","unstructured":"Verma A, Joshi H, Singh V, Anvikar A, Valecha N. Plasmodium vivax msp-3\u03b1 polymorphisms: analysis in the Indian subcontinent. Malar J. 2016;15:1\u201313.","journal-title":"Malar J"},{"key":"185_CR194","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41398-020-01020-z","volume":"10","author":"R Viviani","year":"2020","unstructured":"Viviani R, Messina I, Bosch JE, Dommes L, Paul A, Schneider KL, Scholl C, Stingl JC. Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity. Transl Psychiatry. 2020;10:338.","journal-title":"Transl Psychiatry"},{"key":"185_CR195","doi-asserted-by":"publisher","first-page":"606033","DOI":"10.3389\/fcimb.2020.606033","volume":"10","author":"A Voorberg-van der Wel","year":"2020","unstructured":"Voorberg-van der Wel A, Kocken CHM, Zeeman AM. Modeling Relapsing Malaria: Emerging technologies to study parasite-host interactions in the liver. Front Cell Infect Microbiol. 2020;10:606033.","journal-title":"Front Cell Infect Microbiol"},{"key":"185_CR196","doi-asserted-by":"crossref","unstructured":"Waite JL, Suh E, Lynch PA, Thomas MB. Exploring the lower thermal limits for development of the human malaria parasite.\u00a0Plasmodium falciparum Biol Lett.\u00a02019;15:20190275.","DOI":"10.1098\/rsbl.2019.0275"},{"key":"185_CR197","doi-asserted-by":"publisher","first-page":"e23061","DOI":"10.7554\/eLife.23061","volume":"6","author":"J Watson","year":"2017","unstructured":"Watson J, Taylor WRJ, Menard D, Kheng S, White NJ. Modelling primaquine-induced haemolysis in G6PD deficiency. eLife. 2017;6:e23061.","journal-title":"eLife"},{"key":"185_CR198","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.pt.2016.08.014","volume":"32","author":"NJ White","year":"2016","unstructured":"White NJ. Why do some primate malarias relapse? Trends Parasitol. 2016;32:918\u201320.","journal-title":"Trends Parasitol"},{"key":"185_CR199","volume-title":"Control and elimination of Plasmodium vivax malaria: a technical brief","author":"WHO","year":"2015","unstructured":"WHO. Control and elimination of Plasmodium vivax malaria: a technical brief. World Health Organization; 2015."},{"key":"185_CR200","volume-title":"Global technical strategy for malaria 2016\u20132030 (WHO)","author":"WHO","year":"2015","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030 (WHO). 2015."},{"key":"185_CR201","volume-title":"World Malaria Report 2019","author":"WHO","year":"2019","unstructured":"WHO. World Malaria Report 2019. Geneva: WHO; 2019. [Google Scholar]."},{"key":"185_CR202","unstructured":"WHO. WHO recommends groundbreaking malaria vaccine for children at risk. World Heal Organ 1. 2021. https:\/\/www.who.int\/news\/item\/06-10-2021."},{"key":"185_CR203","unstructured":"World Health Organization. World Malaria Report 2021: Reference Source. Geneva; World Health Organization; 2022."},{"key":"185_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-07711-5","volume":"12","author":"P Wilairatana","year":"2022","unstructured":"Wilairatana P, Masangkay FR, Kotepui KU, De Jesus Milanez G, Kotepui M. Prevalence and risk of Plasmodium vivax infection among Duffy-negative individuals: a systematic review and meta-analysis. Sci Rep. 2022;12:1\u201313.","journal-title":"Sci Rep"},{"key":"185_CR205","doi-asserted-by":"publisher","unstructured":"Zavala F. RTS,S: the first malaria vaccine. J Clin Invest. 2022;132(1):e156588. https:\/\/doi.org\/10.1172\/JCI156588.\u00a0","DOI":"10.1172\/JCI156588"},{"key":"185_CR206","doi-asserted-by":"publisher","first-page":"e0004912","DOI":"10.1371\/journal.pntd.0004912","volume":"10","author":"R Zhang","year":"2016","unstructured":"Zhang R, Lee W-C, Lau Y-L, Albrecht L, Lopes SC, Costa FT, Suwanarusk R, Nosten F, Cooke BM, R\u00e9nia L. Rheopathologic consequence of Plasmodium vivax rosette formation. PLoS Negl Trop Dis. 2016;10:e0004912.","journal-title":"PLoS Negl Trop Dis"},{"key":"185_CR207","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13071-022-05296-6","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wei H, Zhang Y, Zhao Y, Wang L, Hu Y, Nguitragool W, Sattabongkot J, Adams J, Cui L, et al. Genetic diversity of Plasmodium vivax reticulocyte binding protein 2b in global parasite populations. Parasit Vectors. 2022;15:205.","journal-title":"Parasit Vectors"},{"key":"185_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2322-5","volume":"17","author":"D Zhong","year":"2018","unstructured":"Zhong D, Koepfli C, Cui L, Yan G. Molecular approaches to determine the multiplicity of Plasmodium infections. Malar J. 2018;17:1\u20139.","journal-title":"Malar J"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-022-00185-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T11:19:26Z","timestamp":1671103166000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-022-00185-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":208,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s40794-022-00185-3","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}